Literature DB >> 18243713

A binary QSAR model for classification of hERG potassium channel blockers.

Khac-Minh Thai1, Gerhard F Ecker.   

Abstract

Acquired long QT syndrome causes severe cardiac side effects and represents a major problem in clinical studies of drug candidates. One of the reasons for development of arrhythmias related to long QT is inhibition of the human ether-a-go-go-related-gene (hERG) potassium channel. Therefore, early prediction of hERG K(+) channel affinity of drug candidates is becoming increasingly important in the drug discovery process. Binary QSAR models with threshold values at IC(50)=1 and of 10 microM, respectively, were generated using two different sets of descriptors. One set comprising 32 P_VSA descriptors and the other one utilizing a set of descriptors identified out of a large set via a feature selection algorithm. For the full dataset, the power for classification of hERG blockers was 82-88%, which meets prior classification models. Considering the fact that 2D descriptors are fast and easy to calculate, these binary QSAR models are versatile tools for use in virtual screening protocols.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243713     DOI: 10.1016/j.bmc.2008.01.017

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers.

Authors:  Khac-Minh Thai; Gerhard F Ecker
Journal:  Mol Divers       Date:  2009-02-14       Impact factor: 2.943

2.  2D binary QSAR modeling of LPA3 receptor antagonism.

Authors:  James I Fells; Ryoko Tsukahara; Jianxiong Liu; Gabor Tigyi; Abby L Parrill
Journal:  J Mol Graph Model       Date:  2010-03-07       Impact factor: 2.518

3.  ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.

Authors:  Sichao Wang; Youyong Li; Junmei Wang; Lei Chen; Liling Zhang; Huidong Yu; Tingjun Hou
Journal:  Mol Pharm       Date:  2012-03-16       Impact factor: 4.939

4.  Novel Bayesian classification models for predicting compounds blocking hERG potassium channels.

Authors:  Li-li Liu; Jing Lu; Yin Lu; Ming-yue Zheng; Xiao-min Luo; Wei-liang Zhu; Hua-liang Jiang; Kai-xian Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06-30       Impact factor: 6.150

5.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

6.  Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.

Authors:  Ishrat Jabeen; Karin Pleban; Uwe Rinner; Peter Chiba; Gerhard F Ecker
Journal:  J Med Chem       Date:  2012-03-27       Impact factor: 7.446

7.  Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities.

Authors:  Saba Munawar; Monique J Windley; Edwin G Tse; Matthew H Todd; Adam P Hill; Jamie I Vandenberg; Ishrat Jabeen
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

8.  A support vector machine classification model for benzo[c]phenathridine analogues with toposiomerase-I inhibitory activity.

Authors:  Khac-Minh Thai; Thuy-Quyen Nguyen; Trieu-Du Ngo; Thanh-Dao Tran; Thi-Ngoc-Phuong Huynh
Journal:  Molecules       Date:  2012-04-17       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.